Mereo BioPharma Group plc Block listing Interim Review (1953F)

TIDMMPH

RNS Number : 1953F

Mereo BioPharma Group plc

06 March 2020

Mereo BioPharma Group plc

Block Listing Interim Review

Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies, Mereo BioPharma Group plc makes the following update on its block listing:

Date: 6 March 2020

 
 Name of applicant:                                                   Mereo BioPharma Group plc 
 Name of scheme:                                                      2015 Plan 
                                                                       Mereo BioPharma Group plc Share Option Plan 
                                                                     ------------------------------------------------- 
 Period of return:                           From:                    06/09/19            To:      06/03/20 
                                            -----------------------  ------------------  -------  -------------------- 
 Balance of unallotted securities under scheme(s) from previous 
  return:                                                             7,565,929 
                                                                     ------------------------------------------------- 
 Plus: The amount by which the block scheme(s) has been increased 
  since the date of the last 
  return (if any increase has been applied for):                      0 
                                                                     ------------------------------------------------- 
 Less: Number of securities issued/allotted under scheme(s) during 
  period (see LR3.5.7G):                                              0 
                                                                     ------------------------------------------------- 
 Equals: Balance under scheme(s) not yet issued/allotted at end of 
  period:                                                             7,565,929 
                                                                     ------------------------------------------------- 
 
 
 
 Name of contact:                Charles Sermon 
 Telephone number of contact:    +44 (0)333 023 7300 
                                --------------------

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BLRKZGGFKKNGGZM

(END) Dow Jones Newswires

March 06, 2020 02:00 ET (07:00 GMT)

Mereo Biopharma (LSE:MPH)
過去株価チャート
から 12 2024 まで 1 2025